cd160-pe clone by55 antibody Search Results


cd160-pe clone by55 antibody  (Immunotec inc)
90
Immunotec inc cd160-pe clone by55 antibody
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Cd160 Pe Clone By55 Antibody, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/anti+cd160+mab+by55/pmc04314455-72-25-30
Average 90 stars, based on 1 article reviews
cd160-pe clone by55 antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cd4 antibody  (NSJ Bioreagents)
99
NSJ Bioreagents cd4 antibody
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Cd4 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/CD4+Antibody/custom%40f40306%4010%2E1089%2Faid%2E2016%2E0324
Average 99 stars, based on 1 article reviews
cd4 antibody - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
streptavidin-pe-cy7  (Becton Dickinson)
90
Becton Dickinson streptavidin-pe-cy7
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Streptavidin Pe Cy7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/streptavidin+pe/pmc01942017-63-11-12
Average 90 stars, based on 1 article reviews
streptavidin-pe-cy7 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti-cd127-pe r34·34  (Immunotec inc)
90
Immunotec inc anti-cd127-pe r34·34
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Anti Cd127 Pe R34·34, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/cd127+pe/pmc01942017-98-32-35
Average 90 stars, based on 1 article reviews
anti-cd127-pe r34·34 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti-cd57-fitc hnk-1  (Becton Dickinson)
90
Becton Dickinson anti-cd57-fitc hnk-1
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Anti Cd57 Fitc Hnk 1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/anti+cd57/pmc01942017-98-21-24
Average 90 stars, based on 1 article reviews
anti-cd57-fitc hnk-1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
mouse anti human cd73 percp cy5 5  (R&D Systems)
90
R&D Systems mouse anti human cd73 percp cy5 5
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Mouse Anti Human Cd73 Percp Cy5 5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/Human+CD160+PE-conjugated+Antibody/pmc08639424-121-63-103
Average 90 stars, based on 1 article reviews
mouse anti human cd73 percp cy5 5 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
purified mouse igm  (ImmunoTools)
90
ImmunoTools purified mouse igm
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Purified Mouse Igm, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/purified+mouse+igm+antibody/pm25044837-60-88-92
Average 90 stars, based on 1 article reviews
purified mouse igm - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti-cd160 af488 by55  (Becton Dickinson)
90
Becton Dickinson anti-cd160 af488 by55
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Anti Cd160 Af488 By55, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/anti+cd160+af488+by55/pmc08120026__Data_Sheet_1-4-45-46
Average 90 stars, based on 1 article reviews
anti-cd160 af488 by55 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti-ifnγ af700 b27  (Becton Dickinson)
90
Becton Dickinson anti-ifnγ af700 b27
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Anti Ifnγ Af700 B27, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/anti+cd3/pmc08120026__Data_Sheet_1-4-52-53
Average 90 stars, based on 1 article reviews
anti-ifnγ af700 b27 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti-cd14 v500 m5e2  (Becton Dickinson)
90
Becton Dickinson anti-cd14 v500 m5e2
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Anti Cd14 V500 M5e2, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/anti+cd14/pmc08120026__Data_Sheet_1-4-17-18
Average 90 stars, based on 1 article reviews
anti-cd14 v500 m5e2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti-cd19 v500 b43  (Becton Dickinson)
90
Becton Dickinson anti-cd19 v500 b43
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Anti Cd19 V500 B43, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/anti+cd19/pmc08120026__Data_Sheet_1-4-24-25
Average 90 stars, based on 1 article reviews
anti-cd19 v500 b43 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti-cd107a pe-cf594 h4a3  (Becton Dickinson)
90
Becton Dickinson anti-cd107a pe-cf594 h4a3
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Anti Cd107a Pe Cf594 H4a3, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160-pe+clone+by55+antibody/annexin+v/pmc08120026__Data_Sheet_1-4-66-67
Average 90 stars, based on 1 article reviews
anti-cd107a pe-cf594 h4a3 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of CD160 of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).

Journal: Blood Cancer Journal

Article Title: Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia

doi: 10.1038/bcj.2014.92

Figure Lengend Snippet: MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of CD160 of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).

Article Snippet: The CD160FCA incorporates CD2-FITC (Clone S5.2), CD5-APC (Clone L17F12), CD19-PerCP cy5.5 (Clone SJ25C1), CD23-APC (Clone EBVCS-5) and CD45 V500 (Clone Hi30) (BD Biosciences, Oxford, UK); CD160-PE (Clone BY55; IgM isotype; Immunotech, Beckman Coulter, Marseilles, France).

Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction

MRD detection by CD160FCA vs International Standardized Protocols in the validation cohort. ( a ) Comparative assessment of CD160FCA MRD positivity as a percentage of total leucocytes against the ISA methodology ( n =48 samples, P <0.001, R =0.91). ( b ) MRD-positive and -negative cohorts based on the median fluorescence intensity (MFI) of the CD2 neg /CD5 + /CD19 + /CD23 + /CD160 + population.

Journal: Blood Cancer Journal

Article Title: Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia

doi: 10.1038/bcj.2014.92

Figure Lengend Snippet: MRD detection by CD160FCA vs International Standardized Protocols in the validation cohort. ( a ) Comparative assessment of CD160FCA MRD positivity as a percentage of total leucocytes against the ISA methodology ( n =48 samples, P <0.001, R =0.91). ( b ) MRD-positive and -negative cohorts based on the median fluorescence intensity (MFI) of the CD2 neg /CD5 + /CD19 + /CD23 + /CD160 + population.

Article Snippet: The CD160FCA incorporates CD2-FITC (Clone S5.2), CD5-APC (Clone L17F12), CD19-PerCP cy5.5 (Clone SJ25C1), CD23-APC (Clone EBVCS-5) and CD45 V500 (Clone Hi30) (BD Biosciences, Oxford, UK); CD160-PE (Clone BY55; IgM isotype; Immunotech, Beckman Coulter, Marseilles, France).

Techniques: Biomarker Discovery, Fluorescence